A detailed history of New York State Common Retirement Fund transactions in Greenwich Life Sciences, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 6,000 shares of GLSI stock, worth $70,500. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,000
Previous 6,000 -0.0%
Holding current value
$70,500
Previous $104,000 17.31%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$12.07 - $19.04 $72,420 - $114,240
6,000 New
6,000 $104,000
Q2 2022

Aug 04, 2022

SELL
$7.14 - $20.36 $24,990 - $71,260
-3,500 Reduced 99.04%
34 $0
Q4 2021

Feb 02, 2022

SELL
$21.76 - $39.43 $174 - $315
-8 Reduced 0.23%
3,534 $86,000
Q3 2021

Nov 02, 2021

BUY
$38.65 - $46.11 $1,623 - $1,936
42 Added 1.2%
3,542 $138,000
Q2 2021

Aug 02, 2021

BUY
$31.24 - $53.6 $109,340 - $187,600
3,500 New
3,500 $157,000

Others Institutions Holding GLSI

About Greenwich LifeSciences, Inc.


  • Ticker GLSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,848,200
  • Market Cap $151M
  • Description
  • Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...
More about GLSI
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.